San Francisco, CA
AliveCor, Inc., headquartered in San Francisco, CA, has developed the FDA-cleared and CE-marked AliveCor Heart Monitor for iPhone. This clinical-quality, cost effective mobile ECG device enables patients to monitor their heart health anywhere, at any time, and provides medical professionals with an additional heart health assessment tool.
The AliveCor Heart Monitor is available to medical professionals and patients in the U.S., U.K. and Ireland and health conscious individuals in the U.K. and Ireland to record, display, store, and transfer single-channel electrocardiogram (ECG) rhythms.
This mobile ECG device has been used in clinical studies at the University of Oklahoma Health Sciences Center, the USC Center for
Body Computing, and other institutions demonstrating accuracy, usability, and the ability to use the device for community screening. These studies have been published in the Journal of Cardiovascular Electrophysiology and International Journal of Cardiology and abstracts were presented in 2012 at ACC, HRS, and AHA scientific sessions.
In 2011, AliveCor raised $3.3M in a Series A financing with Burrill & Company, Qualcomm Incorporated, acting through its venture investment arm, Qualcomm Ventures, and the Oklahoma Life Science Fund. In June, 2012, AliveCor raised $10.5M in a Series B financing with lead investors, Khosla Ventures and Burrill & Company, with participation from Qualcomm Incorporated, acting through its venture investment arm, Qualcomm Ventures, and the Oklahoma Life Science Fund.